GPX4 and gastric cancer: Recent studies demonstrate that NAA10-mediated lactylation of NSUN2 at residues K216 and K389 depletes glutathione levels and compromises GPX4 activity, thereby conferring resistance to ferroptosis in gastric cancer cells (An et al., 2024).